Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency

Triple-negative breast cancer (TNBC) is a highly aggressive disease with historically poor outcomes, primarily due to the lack of effective targeted therapies. Here, we established a drug sensitivity prediction model based on the homologous recombination deficiency (HRD) using 83 TNBC patients from...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Gaoming, Yang, Yiran, Xie, Aimin, Jiang, Zedong, Liao, Jianlong, Yan, Min, Zhou, Yao, Zhu, Jiali, Hu, Jing, Zhang, Yunpeng, Xiao, Yun, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913497/
https://www.ncbi.nlm.nih.gov/pubmed/35281113
http://dx.doi.org/10.3389/fcell.2022.845950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913497/
https://www.ncbi.nlm.nih.gov/pubmed/35281113
http://dx.doi.org/10.3389/fcell.2022.845950

Ejemplares similares